Progress in nanotechnology for healthcare

Minimally Invasive Therapy and Allied Technologies

Volumn 19, Issue 3, 2010, Pages 127-135

  Raffa, V ^a   Vittorio, O ^a   Riggio, C ^a   Cuschieri, A ^a,b  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Carbon nanotubes; Controlled drug delivery; Electro chemotherapy; Electro stimulation; Healthcare; Nanomaterials; Nanotechnology

Indexed keywords

BORON NITRIDE NANOTUBE; CARBON NANOTUBE; CONTRAST MEDIUM; DENDRIMER; LIPOSOME; MACROGOL; NANOCAPSULE; NANOMATERIAL; NANOSPHERE; QUANTUM DOT; SINGLE WALLED NANOTUBE;

BIOCOMPATIBILITY; CONTROLLED DRUG RELEASE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTROCHEMOTHERAPY; ELECTROSTIMULATION THERAPY; HEALTH CARE; HUMAN; NANOMEDICINE; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING;

DENDRIMERS; ELECTROCHEMOTHERAPY; EQUIPMENT AND SUPPLIES; HUMANS; LIPOSOMES; NANOCAPSULES; NANOMEDICINE; NANOTUBES, CARBON; QUANTUM DOTS; TECHNOLOGY, MEDICAL;

EID: 77952989982     PISSN: 13645706     EISSN: 13652931     Source Type: Journal    
DOI: 10.3109/13645706.2010.481095     Document Type: Review

References (39)

1. Consumer Products Inventory - http://www.nanotechproject. org/inventories/consumer.
2. Allhoff F. The coming era of nano medicine. Am J Bioethics. 2009;9:3-11.
3. Jain KK. Nanomedicine: Application of Nanobiotechnology in Medical Practice. Med Princ Pract. 2008;17:89-101.
4. EU Technology Platform on Nanomedicine. http://www.etpnanomedicine. eu/public.
5. Emerich DF, Halberstadt C, Thanos C. Role of Nanobiotechnology in Cell-Based Nanomedicine: A Concise Review. J Biomed Nanotech. 2007;3:235-244
6. Kroto HW, Heath JR, O'Brien SC, Curl RF, Smalley RE. C60: Buckminsterfullerene. Nature. 1985;318:162-163
7. Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354:56-58
8. Raffa V, Ciofani G, Nitodas S, Karachalios T, D'Alessandro D, Masini M, et al. Can the properties of carbon nanotubes influence their internalization by living cells? Carbon. 2008;46:1600-1610
9. Raffa V, Ciofani G, Vittorio O, Pensabene V, Cuschieri A. Carbon nanotube-enhanced cell electropermeabilisation, Bioelectrochemistry. 2009 [e-published ahead of print, Nov. 2].
10. Raffa V, Ciofani G, Vittorio O, Riggio C, Cuschieri A. Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine (future medicine). 2010;5:89-97.
11. Raffa V, Vittorio V, Ciofani G, Pensabene V, Cushieri A. Cell creeping and controlled migration by magnetic carbon nanotubes. Nanoscale Res Lett. 2010;5:257-262
12. Rubio A, Corkill JL, Cohen ML. Theory of graphitic boron nitride nanotubes Phys Rev B. 1994;49:5081-5084
13. Raffa V, Ciofani G, Cuschieri A. Enhanced low voltage cell electropermeabilization by boron nitride nanotubes. Nanotechnology. 2009;20:075104.
14. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging, physicochemical characteristics and clinical applications a review. J Drug Target. 1998;6:167-174
15. Maenosono S, Suzuk T I, Saita S. Superparamagnetic FePt nanoparticles as excellent MRI contrast agents. Journal of Magnetism and Magnetic Materials. 2009;320:9:L79-L83.
16. Terreno E, Delli Castelli D, Cabella C, Dastrú W, Sanino A, Stancancello J, et al. Paramagnetic liposomes as innovative contrast agents for Magnetic Resonance (MR) molecular imaging application. Chemistry & Biodiversity. 2008;5: 1901-1912
17. www.marvene-project.org.
18. Kukoswka-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005;65: 5317-5324
19. Vladimir PT. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery. 2005;4:145-160
20. Koo OM, Rubenstein I, On yuksel H. Camptothecin in sterically stabilized phospholipid micelles: A novel nanomedicine. Nanomedicine. 2005;1:77.
21. Kaminskas LM, Kelly BD, McLeod VM, Boyd BJ, Krippner GA, Williams ED, et al. Pharmacokinetics and tumor disposition of PEGylated, Methotrexate conjugated Poly-l-lysine Dendrimers. Mol Pharmaceutics. 2009;6: 1190-1204.
22. Langer R. Drug delivery and targeting. Nature. 1998;392: 5-10.
23. Kumaria A, Yadava SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces. 2010;75:1-18.
24. Ashoori RC, Stormer HL, Weiner JS, Pfeiffer NL, Baldwin KW, West KW. N-electron ground state energies of a quantum dot in magnetic field. Phys. Rev. Lett. 1992;71: 613-616
25. Wan Hui, Shih LY, Shih WH. Synthesis and Characterization of Aqueous Carboxyl-Capped CdS Quantum Dots for Bioapplications. Ind Eng Chem Res. 2007;46:2013-2019
26. Bakalova R, Zhelev Z, Aoki L, Masamoto K, Mileva M, Obata T. Multimodal Silica-Shelled Quantum Dots: Direct Intracellular Delivery, Photosensitization, Toxic, and Microcirculation Effects. Bioconjugate Chem. 2008;19: 1135-1142
27. Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, et al. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol Lett. 2007;168:121-131
28. Vaisman L, Wagner H, Marom G. The role of surfactants in dispersion of carbon nanotubes. Adv Colloid Interface Sci. 2006;(128-130):37-46.
29. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci. 2007;100:303-315
30. Raffa V, Menciassi A, Pensabene V, Ciofani G, Dario P. Method and device for non-invasive in vivo electroporation mediated by carbon nanotubes PCT/IB2007/054754, November 22, 2007.
31. Wörle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006;6:1261-1268
32. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;513:423-428
33. Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. PNAS. 2006;103-9:3357-3362
34. Bardi G, Tognini P, Ciofani G, Raffa V, Costa M, Pizzorusso T. Pluronic coated carbon nanotubes do not induce degeneration of cortical neurons in vivo and in vitro. Nanomedicine: NBM. 2009;5:96-104.
35. Vittorio O, Raffa V, Cuschieri A. Biocompatibility of multiwall carbon nanotubes on human neuroblastoma cell line and effects of metal impurity and surface oxidation. Nanomedicine: NBM. 2009;5:424-431
36. Lacerda L, Raffa V, Prato M, Bianco A, Kostarelos K. Cell- Penetrating Carbon Nanotubes in the Delivery of Therapeutics, Nano Today. 2007;2:38-43.
37. Foldvari M, Bagonluri M. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues, Nanomed. 2008;4:183-200.
38. Shi Kam NW, Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA. 2005;102:11600-11605
39. Gannon CJ, Cherukuri P, Yakobson BI, et al. Carbon Nanotube-enhanced Thermal Destruction of Cancer Cells in a Noninvasive Radiofrequency Field. Cancer. 2007;110: 2654-2655